We are live on
!
Find out more
BCAM
Boston Common Asset Management Portfolio holdings
AUM
$1.69B
1-Year Est. Return
28.29%
This Fund
S&P 500
This Quarter
Est. Return
-14.48%
1 Year Est. Return
+28.29%
3 Year Est. Return
+54.94%
5 Year Est. Return
+54.02%
10 Year Est. Return
+260.31%
AUM
$709M
AUM Growth
-$149M
(-17%)
Cap. Flow
+$14.6M
Cap. Flow
% of AUM
2.05%
Top 10 Holdings %
Top 10 Hldgs %
27.97%
Holding
221
New
11
Increased
109
Reduced
55
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$24.9M |
| 2 |
Gilead Sciences
GILD
|
+$7.62M |
| 3 |
CERN
Cerner Corp
CERN
|
+$6.19M |
| 4 |
Alexandria Real Estate Equities
ARE
|
+$4.64M |
| 5 |
Procter & Gamble
PG
|
+$4.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FITB
Fifth Third Bancorp
FITB
|
+$7.87M |
| 2 |
Portland General Electric
POR
|
+$7.87M |
| 3 |
UnitedHealth
UNH
|
+$7.28M |
| 4 |
Alcon
ALC
|
+$6.41M |
| 5 |
Royal Caribbean
RCL
|
+$5.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.6% |
| 2 | Healthcare | 18.14% |
| 3 | Financials | 12.44% |
| 4 | Consumer Discretionary | 10% |
| 5 | Communication Services | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alibaba
BABA
$269B
| $36M | 5.08% |
185,221
-17,774
| -9% | -$3.71M |
|
2
Microsoft
MSFT
$2.84T
| $27M | 3.81% |
171,127
-2,419
| -1% | -$398K |
|
3
TSMC
TSM
$2.09T
| $22.4M | 3.15% |
467,823
-94,995
| -17% | -$5.2M |
|
|
4
GSK
GSK
$103B
| $22.1M | 3.12% |
+466,518
| New | +$24.9M |
|
5
Apple
AAPL
$4.89T
| $17.6M | 2.48% |
277,104
-5,536
| -2% | -$407K |
|
6
Verizon
VZ
$194B
| $16M | 2.25% |
296,901
+14,678
| +5% | +$840K |
|
7
Alphabet (Google) Class C
GOOG
$3.9T
| $15.6M | 2.19% |
267,500
-580
| -0.2% | -$39.4K |
|
|
UN
8
DELISTED
Unilever NV New York Registry Shares
UN
| $13.9M | 1.96% |
285,256
+9,730
| +4% | +$532K |
|
9
Novartis
NVS
$295B
| $13.3M | 1.88% |
161,883
+5,780
| +4% | +$516K |
|
10
Visa
V
$677B
| $12.7M | 1.8% |
79,080
-1,974
| -2% | -$372K |
|
|
11
Gilead Sciences
GILD
$161B
| $12.2M | 1.72% |
163,364
+110,214
| +207% | +$7.62M |
|
12
Biogen
BIIB
$29.9B
| $11.9M | 1.68% |
37,755
+260
| +0.7% | +$78.9K |
|
13
Merck
MRK
$324B
| $11.8M | 1.67% |
161,142
+21,413
| +15% | +$1.68M |
|
14
SAP
SAP
$187B
| $10.4M | 1.47% |
94,310
-718
| -0.8% | -$90.6K |
|
15
Citigroup
C
$222B
| $9.33M | 1.32% |
221,463
+29,289
| +15% | +$1.97M |
|
16
Home Depot
HD
$332B
| $8.57M | 1.21% |
45,922
-348
| -0.8% | -$76.4K |
|
17
HDFC Bank
HDB
$119B
| $8.55M | 1.21% |
444,830
+32,186
| +8% | +$866K |
|
18
Morgan Stanley
MS
$337B
| $8.43M | 1.19% |
247,926
+25,222
| +11% | +$1.19M |
|
19
Mondelez International
MDLZ
$77.7B
| $8.14M | 1.15% |
162,536
-4,084
| -2% | -$221K |
|
|
NVO
20
Novo Nordisk
NVO
$216B
| $8.09M | 1.14% |
268,844
+12
| +0% | +$357 |
|
21
Micron Technology
MU
$1.04T
| $7.86M | 1.11% |
186,864
+24,431
| +15% | +$1.27M |
|
22
Philips
PHG
$25.4B
| $7.57M | 1.07% |
237,012
+43,560
| +23% | +$1.54M |
|
23
Walt Disney
DIS
$165B
| $7.22M | 1.02% |
74,781
-12,881
| -15% | -$1.63M |
|
24
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.9B
| $7.17M | 1.01% |
351,547
+59,622
| +20% | +$1.88M |
|
25
Kimberly-Clark
KMB
$36.4B
| $7.03M | 0.99% |
54,971
+493
| +0.9% | +$68.2K |
|
Similar funds
GAM
FACM
TCBWMS
PP
ISS
BA
RMC
BCM
Boston Common Asset Management's Q1 2020 Portfolio in Review
As of Q1 2020, Boston Common Asset Management held 221 positions worth $709M, down 17% from $858M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Boston Common Asset Management's Q1 2020 filing shows 11 new, 109 increased, 55 reduced and 18 closed positions. Its largest new stake was GSK: 466,518 shares worth $22.1M. The largest sale was Fifth Third Bancorp, an estimated $7.87M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Boston Common Asset Management's largest Q1 2020 buy was GSK: 466,518 shares worth $22.1M.
- Boston Common Asset Management added most to Gilead Sciences in Q1 2020, an estimated $7.62M increase.
- Boston Common Asset Management's biggest Q1 2020 reduction was Alcon, cutting an estimated $6.41M.
- Boston Common Asset Management fully exited Fifth Third Bancorp in Q1 2020, selling an estimated $7.87M.
- Boston Common Asset Management's ten largest holdings make up 28% of its $709M portfolio in Q1 2020.
- Boston Common Asset Management opened 11 new positions and closed 18 in Q1 2020.
- Boston Common Asset Management's portfolio value fell 17% quarter-over-quarter to $709M.
Based on Boston Common Asset Management's 13F filing for Q1 2020, filed 8 May 2020.